Americans are increasingly using cryptocurrencies to purchase peptides—drugs marketed as aids for weight loss, muscle gain, and anti-aging. According to my data, in the first quarter of 2026, sellers of such substances received $32 million in digital assets from customers, a 700% increase compared to the same period last year. This is not just a statistic—it is a signal of the formation of a new, rapidly growing segment of the crypto economy.
Why Bitcoin Has Become the Preferred Payment Method
Traditional banks and payment systems, such as Visa and Mastercard, refuse to service peptide sellers due to high compliance risks and the uncertain legal status of these drugs. As a result, many suppliers accept payment exclusively in Bitcoin. For some buyers, this becomes their first experience with cryptocurrencies. For example, a 49-year-old marketer from the US, seeking retatrutide (an analog of Eli Lilly's drug), reached a Chinese supplier who agreed to ship 20 vials for $240—while on the US market, a similar purchase would have cost him $300 monthly. The seller accepted only digital assets, forcing the buyer to purchase Bitcoin for the first time in his life.
Stages of Explosive Growth
Analyzing on-chain data, I identify three key stages in the development of this market. Until 2025, it remained a niche "underground" with a monthly inflow of about $200,000. Then the topic came to the attention of the Make America Healthy Again movement, and its growth coincided with the appointment of Robert F. Kennedy Jr. as head of the US Department of Health and Human Services. However, the real leap occurred at the end of 2025—after peptides went viral in the TikTok subculture of looksmaxxing, focused on improving appearance and physical fitness. The average monthly inflow quadrupled to $9.9 million, and in peak months exceeded $10 million.
Market Structure: From Bitcoin to Stablecoins
The market is extremely uneven. The bulk of transactions is concentrated among a narrow group of large sellers with a broad customer base. Small players experiment with different coins, but large suppliers almost exclusively use Bitcoin and stablecoins. Among sellers with an average deposit of $1,000 or more, "stablecoins" dominate—this is logical as they protect against volatility in large and cross-border purchases.
Raw materials for peptides are mainly produced in China. According to my data, over three quarters of last year, imports from China to the US roughly doubled—to over $300 million. Some suppliers entered this niche from the drug trade. For example, the Chinese company Bigreat Technology, which previously supplied precursors for fentanyl and amphetamines to Russia and Kazakhstan, created a separate legal entity—Zhengzhou DEPU Technology—to sell cosmetic peptides.
Expert Opinion
This case is a classic example of how regulatory restrictions and the uncertain legal status of a product push the market toward cryptocurrencies. I see parallels here with the early stages of darknet markets like Silk Road: first niche demand, then explosive growth, and, as a consequence, inevitable tightening of control. For the crypto industry, this is a dual signal: on one hand, an increase in the number of users; on the other, the risk of reputational damage due to association with gray areas of the economy.